
zzso factors are among the zzso causes of fatigue, a highly prevalent symptom in the cancer population, with serious impact on patients' quality of zzso zzso of the zzso zzso may play a role by reducing energy production through fatty acid zzso We present preliminary data of an zzso zzso study to determine safety and zzso tolerated dose zzso of 1 week of zzso supplementation in cancer patients with fatigue and zzso zzso Patients who met zzso criteria underwent zzso level zzso zzso percent of these patients zzso had zzso zzso zzso data analysis of 13 patients showed that total zzso increased from zzso zzso zzso to zzso zzso zzso zzso zzso zzso after 1 week of supplementation zzso zzso zzso and free zzso increased from zzso zzso zzso to zzso zzso zzso zzso zzso zzso zzso measures were fatigue zzso zzso depression zzso sleep disruption zzso and performance status zzso Median zzso zzso zzso score at baseline was 73 zzso zzso versus 50 zzso zzso after zzso supplementation zzso zzso zzso zzso score at baseline was 29 zzso zzso and 22 zzso zzso after 1 week zzso zzso zzso zzso at baseline was zzso zzso zzso and zzso zzso zzso after 1 week zzso zzso zzso zzso score did not change significantly zzso zzso zzso We are currently conducting a randomized, zzso zzso study to rigorously assess the role of zzso for the treatment of fatigue and depression in cancer zzso 

